Latest Commercialization News

AdAlta Limited has announced a renounceable rights issue to raise up to $1.3 million, aiming to accelerate its ‘East to West’ cellular immunotherapy strategy and explore new strategic options.

ClearVue Technologies has secured its first commercial rooftop contract in Sydney’s CBD, supplying innovative solar glass for the City Tattersalls Club redevelopment to boost sustainability and energy efficiency.

Nanoveu Limited has successfully raised $2.3 million through a share placement to accelerate development and commercialization of its cutting-edge semiconductor, 3D visualization, and solar coating technologies.

GPT Group unveiled a strategic pivot towards co-investment alongside capital partners, reporting resilient 2024 earnings and expanding its retail management platform through key partnerships and asset acquisitions.

Dimerix Limited has announced a US licensing transaction for its Phase 3 asset DMX-200 targeting FSGS, alongside progress updates on its clinical trial. The move underscores the company’s push to address a rare kidney disease with no approved therapies.

Rewardle Holdings reported a strong March quarter with positive operational cash flow of $1.36 million, driven by its strategic partnership with MedTech firm CloudHolter, while progressing towards ASX relisting.

Solstice Minerals has initiated a significant Reverse Circulation drilling campaign targeting advanced gold prospects in Western Australia, aiming to expand on promising historical intercepts and recent exploration success.

Dimerix has inked an exclusive US licensing agreement with Amicus Therapeutics for DMX-200, a promising Phase 3 treatment for FSGS, unlocking $30 million upfront and up to $560 million in milestones.

Imricor Medical Systems has initiated its first MRI-guided atrial flutter ablation procedures at Semmelweis University in Budapest, marking a significant expansion of its real-time MRI technology in Europe.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Everest Metals has secured a $50,000 CSIRO Kick-Start voucher to conduct advanced geochemical studies on rubidium, lithium, and caesium at its Mt Edon project, aiming to enhance recovery processes and exploration targeting over nine months.

Tempest Minerals Ltd has announced a maiden inferred resource estimate of 63.5 million tonnes at 30.6% iron for its Remorse Magnetite Iron Deposit, marking a pivotal step from exploration to development at the Yalgoo Project.